OAC
ASND icon

OMERS Administration Corp’s Ascendis Pharma A/S ASND Stock Holding History

OMERS Administration Corp’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,700
Closed -$1.13M – 1063
2025
Q3 		$1.13M Buy
+5,700
New +$1.06M 0.01% 534

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OMERS Administration Corp's ASND Position: Q4 2025 in Review

OMERS Administration Corp sold out of Ascendis Pharma A/S (ASND) in Q4 2025, closing a stake of 5,700 shares — an estimated $1.13M sold.

OMERS Administration Corp first reported a position in ASND in Q3 2025 and held it in 1 quarter. The position peaked at $1.13M in Q3 2025. 302 funds tracked by Wall St. Rank hold ASND as of Q4 2025.

  • OMERS Administration Corp reported no remaining Ascendis Pharma A/S position as of Q4 2025 after selling out during the quarter.
  • OMERS Administration Corp sold 5,700 Ascendis Pharma A/S shares in Q4 2025, an estimated $1.13M.
  • OMERS Administration Corp first reported a position in Ascendis Pharma A/S in Q3 2025 and held it in 1 quarter.
  • OMERS Administration Corp's Ascendis Pharma A/S position peaked at $1.13M in Q3 2025.
  • 302 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2025.

Based on OMERS Administration Corp's 13F filing for Q4 2025, filed 13 Feb 2026.